NCT03975712

Brief Summary

The goal of the study was to evaluate the pravalence of Rathke's Cleft Cyst of children under 15 years of age and demonstrate that their prevalence is higher than for patients over 15 years of age, due to their embryonic origin. It is also aimed to describe their aspect on MRI and evaluate the interobserver agreement in the detection of Rathke's Cleft Cyst.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
460

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2017

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2019

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 5, 2019

Completed
Last Updated

June 5, 2019

Status Verified

May 1, 2019

Enrollment Period

1 year

First QC Date

May 27, 2019

Last Update Submit

June 4, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Presence or absence of a strictly intra-pituitary cystic lesion which localization and signal was compatible with an RCC, which type was defined according to its signal

    All MRI performed on a period of one year in children under 15 years will be taken into account

Secondary Outcomes (4)

  • Maximum anteroposterior diameter (parallel to the bi-callous plane) of the cyst measured in sagittal section

    All MRI performed on a period of one year in children under 15 years will be taken into account

  • Cyst signal on T2-weighted spin echo sequence compared to cerebrospinal fluid (hypo / iso / hyper signal) and T1-weighted compared to cerebral white matter (hypo / iso / hyper signal)

    All MRI performed on a period of one year in children under 15 years will be taken into account

  • Motive for which brain MRI was performed

    All MRI performed on a period of one year in children under 15 years will be taken into account

  • Dimensions of pituitary

    All MRI performed on a period of one year in children under 15 years will be taken into account

Interventions

Not applicable, no intervention

Eligibility Criteria

Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

children aged 15 or under at the time that an MRI was performed exploring the sellar region

You may qualify if:

  • children aged 15 or under at the time that an MRI was performed exploring the sellar region
  • MRI with at least T1 spin echo (SE) sagittal slices with a slice thickness of 2.5 or 3 mm with inter-slice spacing of 0.3 mm and T2 SE with a slice thickness of 2 mm and inter-slice spacing of 0.2 mm.

You may not qualify if:

  • Patients with incomplete MRI protocol
  • Patients whose MRI images had artifacts (patient movement, presence of dental material)
  • Patients with suspected pituitary pathology due to endocrine symptomatology (growth retardation, puberty delay, diabetes insipidus) that could be attributed to an intrasellar injury were also excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire

Besançon, France

Location

MeSH Terms

Conditions

Central Nervous System Cysts

Condition Hierarchy (Ancestors)

Central Nervous System NeoplasmsNervous System NeoplasmsNeoplasms by SiteNeoplasmsNervous System MalformationsNervous System DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 27, 2019

First Posted

June 5, 2019

Study Start

November 1, 2017

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

June 5, 2019

Record last verified: 2019-05

Data Sharing

IPD Sharing
Will not share

Locations